U.S. regulators and the drug industry want to extend by two months the deadline for the Food and Drug Administration to approve or reject new drugs. The FDA said it would need an extra 60-day “filing date” before the clock starts ticking on its 10-month deadline to review new drugs, or six months for a [...]
According to Forbes “ The 31 pharmaceutical companies comprising its main trade group spent $48.5 billion on research and development last year. All told, the pharmaceutical sector has spent $550 billion on R&D since 2000. That half-trillion dollars of research has yielded more than 400 new medicines” But of 12 cancer drugs approved in 2012, 11 [...]
You would think that with the changing healthcare environment and so many products coming off patent that most pharma companies would take this chance to look in the mirror and redefine their organizational structures to become more customer focused with speed and quality but unfortunately that’s not the case.
Digital advertising spending by the US healthcare and pharmaceutical industry will hit $1.58 billion in 2012 and rise to $2.48 billion by 2016. But even as marketers move larger percentages of their budgets online, expiring patents and regulatory challenges will conspire to temper spending growth. ”Most pharma marketers see digital marketing’s potential but remain rooted [...]
The steady drumbeat of corporate scandals and big fines for pharma in recent years has made many observers wonder what happened to corporate responsibility. Law professor Joel Bakan has a contrarian answer: Corporate responsibility never existed in the first place. He persuasively argues that corporations are “pathological” to the core, spurred by tradition and legal [...]